Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Behav Health Serv Res. 2018 Apr;45(2):160–173. doi: 10.1007/s11414-017-9576-5

Table 2.

Days of Treatment, Alcohol and Drug Use by Condition

Time Total
% / Mean by Condition
Comparisons (RMC-PC v SBIRT)
Mean S.D. SBIRT as Usuala SBIRT+RMC-PCb OR /Cohen’s d X2 /t-test p-value

N N=142 N=50 N=92
Treatment Reported at Dischargec Received Any AOD Treatmentd 46% 14% 64% 10.98 32.73 0.000
Days of any AOD Treatmentd 44.63 53.75 10.38 63.24 0.98 7.38 0.000

Days Used Alcohole Intake 7.42 10.36 8.68 6.73 -0.19 -1.07 0.285
Follow-up 2.74 6.05 3.66 2.24 -0.23 -1.34 0.182
Change -4.68 8.96 -5.02 -4.49 0.06 0.34 0.737

Days Used Illicit Drugs or Misused Prescription Medicatione Intake 21.40 11.77 15.98 24.35 0.71 3.91 0.000
Follow-up 2.67 6.64 2.82 2.60 -0.03 -0.19 0.853
Change -18.67 13.34 -12.88 -21.75 -0.67 -3.85 0.000

Days Used Alcohol or Other Drugse Intake 24.87 9.42 20.72 27.12 0.68 3.51 0.001
Follow-up 5.25 8.94 6.24 4.71 -0.17 -0.91 0.363
Change -19.62 12.60 -14.48 -22.41 -0.63 -3.63 0.000
a

SBIRT: Screening, Brief Intervention, and Referral to Treatment

b

RMC-PC: Recovery Management Checkups for Primary Care

c

Data collected at discharge from treatment or 6-month interview – whichever comes first.

d

AOD Treatment: alcohol or other drug use treatment, including outpatient, intensive outpatient, inpatient, or methadone.

e

Out of 30 days at intake and follow-up, change calculated as follow-up minus intake; range = -30 to +30